Audiovestibular clinician experiences and opinions about cisplatin vestibulotoxicity
Open Access
- 19 May 2020
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 277 (12) , 3283-3293
Abstract
Purpose: Vestibulotoxicity associated with cisplatin chemotherapy is known to exist, but the extent, severity, and impact is unclear from the literature. This study explored knowledge, experiences, and opinions of audiovestibular professionals about cisplatin vestibulotoxicity. Methods: An online survey was disseminated to clinicians working in the audiovestibular field. Results: Ninety-three respondents participated in the survey. Most professionals were aware of potential vestibulotoxicity associated with cisplatin chemotherapy. Thirty-three percent of the respondents reported that they had seen patients with cisplatin vestibulotoxicity. Forty percent of them were confident in making the diagnosis and in managing the patient in this situation. The prevalence and impact of vestibulotoxicity including practicality of the assessment should be considered when designing an effective vestibulotoxicity screening protocol. Conclusion: This study provides a better understanding of cisplatin vestibulotoxicity from the perspectives of audiovestibular clinicians, which will underpin appropriate detection and management of the condition.Keywords
This publication has 30 references indexed in Scilit:
- Bilateral vestibulopathy treatment: update and future directionsThe Egyptian Journal of Otolaryngology, 2016
- Bilateral Vestibular Hypofunction: Insights in Etiologies, Clinical Subtypes, and DiagnosticsFrontiers in Neurology, 2016
- Bilateral Vestibular Hypofunction: Challenges in Establishing the Diagnosis in AdultsORL, 2015
- Systematic review of falls in older adults with cancerJournal of Geriatric Oncology, 2015
- The current state of ototoxicity monitoring in New Zealand.2014
- Bilateral Vestibular DeficiencyJAMA Otolaryngology–Head & Neck Surgery, 2014
- Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastomaPediatric Blood & Cancer, 2013
- Clinical diagnosis of bilateral vestibular loss: three simple bedside testsTherapeutic Advances in Neurological Disorders, 2012
- Quality of Life of Patients with Bilateral VestibulopathyAnnals of Otology, Rhinology & Laryngology, 2012
- Causative Factors, Epidemiology, and Follow‐up of Bilateral VestibulopathyAnnals of the New York Academy of Sciences, 2009